You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage IV adult Burkitt lymphoma

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Lymphoma, Burkitt Lymphoma Trial in Milwaukee (Etoposide, Doxorubicin, Cyclophosphamide)

Not yet recruiting
  • B-cell Lymphoma
  • Burkitt Lymphoma
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Jun 11, 2022

Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma, Ann Arbor Stage III Follicular Lymphoma Trial

Active, not recruiting
  • Ann Arbor Stage II Follicular Lymphoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 3, 2022

Adult Solid Tumor, Diffuse Large B Cell Lymphoma, Burkitt Lymphoma Trial in United Kingdom (AZD3965)

Completed
Has Results
  • Adult Solid Tumor
  • +2 more
  • Sutton, London, United Kingdom
  • +6 more
Feb 10, 2022

Lymphoma, Non-Hodgkin's, Adult Trial in Rosario, Caba (Evaluation of first line treatment in patients with stage I and II LBCL)

Recruiting
  • Lymphoma, Non-Hodgkin's, Adult
  • Evaluation of first line treatment in patients with stage I and II LBCL
  • Paraná, Entre Ríos, Argentina
  • +6 more
Dec 29, 2022

Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Previously Treated Myelodysplastic Syndrome, Refractory Chronic

Completed
Has Results
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • +115 more
  • Fludarabine Phosphate
  • +6 more
  • Denver, Colorado
  • +10 more
Oct 29, 2019

Aggressive B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 3 Follicular

Recruiting
  • Aggressive B-Cell Non-Hodgkin Lymphoma
  • +19 more
  • CD47 Antagonist ALX148
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

Unresectable Melanoma, Metastatic Melanoma, Stage III NSCLC Trial in Louisville, New York (IOV-4001)

Recruiting
  • Unresectable Melanoma
  • +3 more
  • IOV-4001
  • Louisville, Kentucky
  • +2 more
Nov 21, 2022

Follicular Lymphoma Trial in Worldwide (Mosunetuzumab (IV), Tocilizumab, Lenalidomide)

Recruiting
  • Follicular Lymphoma
  • Mosunetuzumab (IV)
  • +3 more
  • Duarte, California
  • +21 more
Jan 10, 2023

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma Trial in Seattle

Terminated
Has Results
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +12 more
  • Laboratory Biomarker Analysis
  • ROR1 CAR-specific Autologous T-Lymphocytes
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 11, 2022

AIDS-Related Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma Trial in France, United

Active, not recruiting
  • AIDS-Related Hodgkin Lymphoma
  • +11 more
  • Brentuximab Vedotin
  • +4 more
  • La Jolla, California
  • +27 more
Jul 27, 2022

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Frankfurt (Main) (Rituximab, Nelarabine, PEG-Asparaginase)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Frankfurt (Main), Germany
    University Hospital of Frankfurt (Main)
Jul 1, 2022

Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Grade 1

Active, not recruiting
  • Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
  • +18 more
  • Anti-ICOS Monoclonal Antibody MEDI-570
  • +2 more
  • Duarte, California
  • +22 more
Jan 18, 2023

Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann

Completed
Has Results
  • Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma
  • +11 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Mountain View, California
  • +90 more
Aug 3, 2022

Ann Arbor Stage IB Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma Trial in United

Active, not recruiting
Has Results
  • Ann Arbor Stage IB Hodgkin Lymphoma
  • +10 more
  • Brentuximab Vedotin
  • Nivolumab
  • Palo Alto, California
  • +8 more
Jul 20, 2022

NSCLC Stage IV, ALK Fusion Protein Expression Trial (Peptide vaccine)

Not yet recruiting
  • NSCLC Stage IV
  • ALK Fusion Protein Expression
  • Peptide vaccine
  • (no location specified)
Jul 21, 2023

Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic

Completed
Has Results
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +99 more
  • fludarabine phosphate
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 30, 2019

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Completed
Has Results
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +99 more
  • alemtuzumab
  • +6 more
  • Denver, Colorado
  • +6 more
Jan 15, 2020

Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)

Completed
  • Male Breast Cancer
  • +7 more
  • propranolol hydrochloride
  • Correlative Studies
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 4, 2022

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)

Completed
  • Chronic Myeloproliferative Disorders
  • +5 more
  • sargramostim
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 3, 2022

Non Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer Trial in United States (BMF-219)

Recruiting
  • Non Small Cell Lung Cancer
  • +16 more
  • Goodyear, Arizona
  • +10 more
Jan 24, 2023

Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Trial in Houston (Radiation Therapy)

Recruiting
  • Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
  • Radiation Therapy
  • Houston, Texas
    M D Anderson Cancer Center
Nov 9, 2021

Advanced Lymphoma, Advanced Malignant Solid Tumor, Advanced Pancreatic Carcinoma Trial in New Haven (BET Bromodomain Inhibitor

Recruiting
  • Advanced Lymphoma
  • +13 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • New Haven, Connecticut
    Yale University Cancer Center LAO
Jun 29, 2022

Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma Trial in India (Acalabrutinib capsule)

Active, not recruiting
  • Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma
  • Acalabrutinib capsule
  • Ahmedabad, India
  • +12 more
Feb 2, 2023

Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with

Recruiting
  • Acute Leukemia
  • +27 more
  • HSCT with TBI Regimen
  • HSCT with Non-TBI Regimen
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Apr 12, 2022

Lymphoma Trial in Scottsdale, Jacksonville, Rochester (biological, drug, genetic, other)

Active, not recruiting
  • Lymphoma
  • pegfilgrastim
  • +8 more
  • Scottsdale, Arizona
  • +2 more
Jan 7, 2022